Literature DB >> 8846647

Cytokines in rheumatoid arthritis.

F A Houssiau1.   

Abstract

An ever-growing number of cytokines that play a critical role as soluble mediators of immune and inflammatory responses are being described. Not surprisingly, most of them have been detected in SF or serum of patients with RA. However, given the numerous interactions within the cytokine network--e.g., agonistic and antagonistic properties and natural inhibitors--one should beware of over-simplistic views, the most so as extrapolation from in vitro and animal models is always a challenge. From a clinical viewpoint, more work is required before measurements of cytokines in RA be used as activity indices and--more importantly--as prognostic marker.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8846647     DOI: 10.1007/bf02215851

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  IL-6 is produced by osteoblasts and induces bone resorption.

Authors:  Y Ishimi; C Miyaura; C H Jin; T Akatsu; E Abe; Y Nakamura; A Yamaguchi; S Yoshiki; T Matsuda; T Hirano
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

2.  Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

Authors:  J A Eastgate; J A Symons; N C Wood; F M Grinlinton; F S di Giovine; G W Duff
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

Review 3.  Interleukin 1: the first interleukin.

Authors:  F S di Giovine; G W Duff
Journal:  Immunol Today       Date:  1990-01

4.  Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.

Authors:  C M Dubois; F W Ruscetti; E W Palaszynski; L A Falk; J J Oppenheim; J R Keller
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

5.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

Authors:  F A Houssiau; J P Devogelaer; J Van Damme; C N de Deuxchaisnes; J Van Snick
Journal:  Arthritis Rheum       Date:  1988-06

6.  Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.

Authors:  P Barrera; A M Boerbooms; E M Janssen; R W Sauerwein; H Gallati; J Mulder; T de Boo; P N Demacker; L B van de Putte; J W van der Meer
Journal:  Arthritis Rheum       Date:  1993-08

Review 7.  Cytokine abnormalities in inflammatory arthritis.

Authors:  P Miossec
Journal:  Baillieres Clin Rheumatol       Date:  1992-06

8.  Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide.

Authors:  S A Stimpson; F G Dalldorf; I G Otterness; J H Schwab
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

Review 9.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.

Authors:  C A Dinarello; R C Thompson
Journal:  Immunol Today       Date:  1991-11

10.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  5 in total

1.  Alpinia galanga extracts downregulate interleukin-1β-induced matrix metalloproteinases expression in human synovial fibroblasts.

Authors:  Peraphan Pothacharoen; Kanyamas Choocheep; Thanyaluck Phitak; Wilart Pompimon; Prachya Kongtawelert
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-12-04       Impact factor: 2.416

Review 2.  Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis.

Authors:  Dae-Seog Lim; Yong-Soo Bae
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

3.  Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages.

Authors:  Mun-Li Yam; Sitti Rahma Abdul Hafid; Hwee-Ming Cheng; Kalanithi Nesaretnam
Journal:  Lipids       Date:  2009-08-05       Impact factor: 1.880

Review 4.  Inflammation induced loss of skeletal muscle.

Authors:  Priya Londhe; Denis C Guttridge
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

5.  Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha.

Authors:  John A Christopherson; Erik L Munson; Douglas M England; Cindy L Croke; Monica C Remington; Melanie L Molitor; David J DeCoster; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2003-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.